 Peter Buttrick
Concepts (556)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 53 | 2018 | 926 | 3.560 |
Why?
| | Heart Ventricles | 18 | 2023 | 712 | 2.270 |
Why?
| | Heart Failure | 21 | 2023 | 1963 | 2.110 |
Why?
| | Cardiomegaly | 20 | 2013 | 161 | 1.900 |
Why?
| | Myocardial Contraction | 22 | 2011 | 316 | 1.880 |
Why?
| | Protein Kinase C | 19 | 2014 | 274 | 1.820 |
Why?
| | Ventricular Dysfunction, Right | 7 | 2023 | 222 | 1.740 |
Why?
| | Myocytes, Cardiac | 13 | 2022 | 457 | 1.590 |
Why?
| | Troponin I | 10 | 2013 | 68 | 1.340 |
Why?
| | Isoenzymes | 17 | 2002 | 285 | 1.080 |
Why?
| | Heart | 21 | 2022 | 608 | 1.000 |
Why?
| | Ventricular Function, Right | 6 | 2023 | 251 | 0.960 |
Why?
| | Myosins | 18 | 2018 | 126 | 0.860 |
Why?
| | Muscle Proteins | 4 | 2022 | 209 | 0.860 |
Why?
| | Phosphorylation | 19 | 2016 | 1571 | 0.800 |
Why?
| | Actin Cytoskeleton | 6 | 2011 | 93 | 0.790 |
Why?
| | Heart-Assist Devices | 3 | 2012 | 486 | 0.770 |
Why?
| | Hypertension, Pulmonary | 8 | 2023 | 1749 | 0.720 |
Why?
| | Cardiomyopathy, Dilated | 6 | 2018 | 352 | 0.720 |
Why?
| | Ventricular Remodeling | 8 | 2023 | 225 | 0.700 |
Why?
| | Protein Kinase C-epsilon | 9 | 2007 | 26 | 0.690 |
Why?
| | Myosin Light Chains | 4 | 2013 | 26 | 0.670 |
Why?
| | Carrier Proteins | 5 | 2022 | 701 | 0.670 |
Why?
| | Scientific Misconduct | 1 | 2019 | 11 | 0.660 |
Why?
| | Physical Conditioning, Animal | 8 | 2006 | 191 | 0.630 |
Why?
| | Rats | 48 | 2013 | 5034 | 0.630 |
Why?
| | Sarcomeres | 7 | 2021 | 89 | 0.630 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 5 | 2011 | 131 | 0.610 |
Why?
| | Stroke Volume | 8 | 2023 | 509 | 0.610 |
Why?
| | Neprilysin | 1 | 2018 | 47 | 0.600 |
Why?
| | Animals | 86 | 2023 | 32102 | 0.590 |
Why?
| | Editorial Policies | 1 | 2017 | 44 | 0.540 |
Why?
| | Calcium | 11 | 2011 | 1103 | 0.540 |
Why?
| | Myocardial Infarction | 8 | 2013 | 931 | 0.530 |
Why?
| | Cardiac Myosins | 2 | 2013 | 29 | 0.520 |
Why?
| | Myocardial Ischemia | 4 | 2019 | 237 | 0.510 |
Why?
| | Gene Expression Regulation | 8 | 2019 | 2353 | 0.510 |
Why?
| | Adrenergic beta-Agonists | 5 | 2002 | 129 | 0.490 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 941 | 0.480 |
Why?
| | Periodicals as Topic | 1 | 2017 | 183 | 0.470 |
Why?
| | Histone Deacetylases | 2 | 2013 | 196 | 0.470 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2021 | 249 | 0.460 |
Why?
| | Serine | 3 | 2013 | 125 | 0.460 |
Why?
| | Ventricular Function, Left | 4 | 2011 | 467 | 0.450 |
Why?
| | Rats, Wistar | 15 | 2006 | 368 | 0.430 |
Why?
| | Valproic Acid | 1 | 2013 | 43 | 0.430 |
Why?
| | Hydroxamic Acids | 1 | 2013 | 80 | 0.430 |
Why?
| | Aortic Valve Stenosis | 2 | 2013 | 253 | 0.420 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 366 | 0.410 |
Why?
| | Mitogen-Activated Protein Kinases | 3 | 2002 | 277 | 0.400 |
Why?
| | Isoproterenol | 6 | 2004 | 110 | 0.400 |
Why?
| | RNA, Messenger | 15 | 2017 | 2574 | 0.370 |
Why?
| | Recovery of Function | 2 | 2011 | 577 | 0.360 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2021 | 183 | 0.350 |
Why?
| | Mice | 27 | 2022 | 15052 | 0.350 |
Why?
| | Apoptosis | 4 | 2002 | 2377 | 0.340 |
Why?
| | Dobutamine | 5 | 2005 | 33 | 0.330 |
Why?
| | Gene Expression | 12 | 2017 | 1435 | 0.330 |
Why?
| | Receptors, Adrenergic, beta | 3 | 2011 | 133 | 0.320 |
Why?
| | Angiotensin Receptor Antagonists | 3 | 1997 | 77 | 0.310 |
Why?
| | Humans | 51 | 2023 | 115587 | 0.310 |
Why?
| | Phosphoserine | 2 | 2007 | 33 | 0.300 |
Why?
| | Cattle | 6 | 2023 | 935 | 0.300 |
Why?
| | Protein Processing, Post-Translational | 5 | 2016 | 401 | 0.300 |
Why?
| | Phenotype | 2 | 2013 | 2829 | 0.300 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2017 | 293 | 0.300 |
Why?
| | Muscle Strength | 1 | 2010 | 275 | 0.290 |
Why?
| | Catecholamines | 5 | 2022 | 97 | 0.290 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2023 | 142 | 0.290 |
Why?
| | Tissue and Organ Procurement | 1 | 2010 | 243 | 0.290 |
Why?
| | Disease Models, Animal | 10 | 2023 | 3580 | 0.290 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 180 | 0.280 |
Why?
| | Pharmacogenetics | 1 | 2008 | 151 | 0.280 |
Why?
| | Glycolysis | 2 | 2012 | 224 | 0.280 |
Why?
| | Mitochondria, Heart | 1 | 2007 | 73 | 0.280 |
Why?
| | Biophysics | 1 | 2007 | 70 | 0.270 |
Why?
| | NAD | 1 | 2007 | 67 | 0.270 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2006 | 61 | 0.270 |
Why?
| | Cytosol | 1 | 2007 | 209 | 0.270 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2006 | 68 | 0.270 |
Why?
| | Mice, Transgenic | 13 | 2018 | 1970 | 0.270 |
Why?
| | Hypertension | 5 | 2007 | 1064 | 0.260 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 446 | 0.260 |
Why?
| | Fibroblasts | 4 | 2020 | 839 | 0.250 |
Why?
| | Models, Animal | 1 | 2007 | 350 | 0.250 |
Why?
| | Hypertension, Renovascular | 3 | 1994 | 11 | 0.250 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 621 | 0.250 |
Why?
| | MAP Kinase Signaling System | 1 | 2006 | 275 | 0.240 |
Why?
| | Male | 37 | 2020 | 55949 | 0.240 |
Why?
| | Models, Biological | 2 | 2021 | 1646 | 0.240 |
Why?
| | Myosin Heavy Chains | 3 | 2004 | 169 | 0.240 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 845 | 0.240 |
Why?
| | Calcineurin | 2 | 2002 | 84 | 0.240 |
Why?
| | Renin-Angiotensin System | 2 | 1996 | 72 | 0.240 |
Why?
| | Gene Transfer Techniques | 3 | 2000 | 148 | 0.220 |
Why?
| | Angiotensin II | 2 | 2001 | 91 | 0.220 |
Why?
| | Cardiovascular Diseases | 3 | 2007 | 1724 | 0.220 |
Why?
| | Female | 47 | 2020 | 59913 | 0.220 |
Why?
| | GATA4 Transcription Factor | 2 | 2020 | 17 | 0.220 |
Why?
| | Chronic Disease | 2 | 2020 | 1598 | 0.220 |
Why?
| | Thromboxane A2 | 2 | 2002 | 12 | 0.210 |
Why?
| | Cardiac Output, Low | 1 | 2002 | 64 | 0.200 |
Why?
| | Rats, Inbred Strains | 14 | 1992 | 376 | 0.190 |
Why?
| | Genetic Therapy | 3 | 2000 | 260 | 0.190 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 609 | 0.190 |
Why?
| | Heart Diseases | 2 | 2019 | 330 | 0.190 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2002 | 85 | 0.190 |
Why?
| | Calcium Signaling | 3 | 2011 | 211 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2004 | 161 | 0.190 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2021 | 794 | 0.190 |
Why?
| | Cyclosporine | 1 | 2001 | 169 | 0.190 |
Why?
| | Biomedical Research | 1 | 2007 | 588 | 0.190 |
Why?
| | Alternative Splicing | 1 | 2022 | 187 | 0.180 |
Why?
| | Organ Size | 12 | 2001 | 434 | 0.180 |
Why?
| | Blood Pressure | 11 | 2012 | 1537 | 0.180 |
Why?
| | Brachial Artery | 1 | 2002 | 173 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 930 | 0.180 |
Why?
| | Adaptation, Physiological | 4 | 2012 | 476 | 0.180 |
Why?
| | Signal Transduction | 9 | 2021 | 4541 | 0.180 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2002 | 171 | 0.180 |
Why?
| | Hemodynamics | 8 | 2011 | 968 | 0.180 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 59 | 0.180 |
Why?
| | RNA, Long Noncoding | 1 | 2022 | 157 | 0.170 |
Why?
| | Tetrazoles | 2 | 1997 | 32 | 0.170 |
Why?
| | Animals, Newborn | 5 | 2011 | 780 | 0.170 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2021 | 120 | 0.170 |
Why?
| | Molecular Sequence Data | 8 | 2012 | 2790 | 0.170 |
Why?
| | Cardiotonic Agents | 3 | 2005 | 119 | 0.170 |
Why?
| | Phototherapy | 1 | 2019 | 24 | 0.170 |
Why?
| | Heart Rate | 8 | 2007 | 701 | 0.170 |
Why?
| | Cell Dedifferentiation | 1 | 2019 | 28 | 0.170 |
Why?
| | Cells, Cultured | 13 | 2021 | 3914 | 0.170 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2018 | 26 | 0.160 |
Why?
| | Autophagosomes | 1 | 2018 | 19 | 0.160 |
Why?
| | Cocaine | 2 | 1991 | 153 | 0.160 |
Why?
| | Body Weight | 10 | 2001 | 867 | 0.160 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2018 | 22 | 0.160 |
Why?
| | Circadian Clocks | 1 | 2019 | 44 | 0.160 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 225 | 0.160 |
Why?
| | Membrane Fusion | 1 | 2018 | 39 | 0.160 |
Why?
| | Imidazoles | 2 | 1997 | 217 | 0.160 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 344 | 0.160 |
Why?
| | In Vitro Techniques | 8 | 2011 | 1044 | 0.160 |
Why?
| | Lysosomes | 1 | 2018 | 125 | 0.150 |
Why?
| | Amphiregulin | 1 | 2018 | 21 | 0.150 |
Why?
| | Adenosine Triphosphatases | 5 | 2005 | 155 | 0.150 |
Why?
| | Systole | 3 | 2005 | 169 | 0.150 |
Why?
| | Filamins | 1 | 2018 | 19 | 0.150 |
Why?
| | Aging | 5 | 2008 | 1631 | 0.150 |
Why?
| | Receptors, Histamine H2 | 1 | 2017 | 8 | 0.150 |
Why?
| | Mice, Inbred C57BL | 8 | 2020 | 4773 | 0.150 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2018 | 93 | 0.150 |
Why?
| | Actomyosin | 1 | 1997 | 10 | 0.150 |
Why?
| | Physical Exertion | 3 | 1988 | 206 | 0.150 |
Why?
| | Activities of Daily Living | 1 | 2020 | 352 | 0.150 |
Why?
| | Period Circadian Proteins | 2 | 2019 | 15 | 0.140 |
Why?
| | Hypoxia | 4 | 2023 | 937 | 0.140 |
Why?
| | Patient Participation | 1 | 2020 | 363 | 0.140 |
Why?
| | Protein Kinase C beta | 6 | 2008 | 24 | 0.140 |
Why?
| | Sex Characteristics | 3 | 2006 | 641 | 0.140 |
Why?
| | Coronary Circulation | 4 | 2004 | 128 | 0.140 |
Why?
| | Angiotensin I | 1 | 1996 | 4 | 0.140 |
Why?
| | Myofibrils | 2 | 2021 | 46 | 0.140 |
Why?
| | Enzyme Inhibitors | 5 | 2002 | 757 | 0.140 |
Why?
| | Middle Aged | 11 | 2020 | 26999 | 0.130 |
Why?
| | Ultrasonography | 2 | 2012 | 641 | 0.130 |
Why?
| | Coronary Artery Disease | 1 | 2002 | 607 | 0.130 |
Why?
| | Amino Acid Substitution | 2 | 2007 | 267 | 0.130 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2015 | 11 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 1996 | 181 | 0.130 |
Why?
| | Time Factors | 8 | 2009 | 6165 | 0.130 |
Why?
| | rho-Associated Kinases | 1 | 2015 | 81 | 0.120 |
Why?
| | Heart Transplantation | 4 | 2011 | 671 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2015 | 84 | 0.120 |
Why?
| | Transcription, Genetic | 3 | 2019 | 1310 | 0.120 |
Why?
| | Blotting, Western | 2 | 2015 | 1153 | 0.120 |
Why?
| | Coronary Vessels | 2 | 1987 | 229 | 0.120 |
Why?
| | Atrial Natriuretic Factor | 2 | 2007 | 58 | 0.120 |
Why?
| | Tetracycline | 1 | 1994 | 11 | 0.120 |
Why?
| | Interleukin-18 | 1 | 2016 | 222 | 0.120 |
Why?
| | Echocardiography | 2 | 2009 | 558 | 0.120 |
Why?
| | Amino Acid Sequence | 4 | 2012 | 2000 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2021 | 1700 | 0.110 |
Why?
| | Renin | 1 | 1993 | 31 | 0.110 |
Why?
| | Cardiac Output | 3 | 2012 | 143 | 0.110 |
Why?
| | Transfection | 3 | 1993 | 866 | 0.110 |
Why?
| | Protein Phosphatase 1 | 1 | 2013 | 28 | 0.110 |
Why?
| | Protein Phosphatase 2 | 1 | 2013 | 30 | 0.110 |
Why?
| | Sodium, Dietary | 1 | 1993 | 36 | 0.110 |
Why?
| | Substance-Related Disorders | 2 | 1991 | 950 | 0.110 |
Why?
| | Antihypertensive Agents | 1 | 1996 | 432 | 0.110 |
Why?
| | Immunohistochemistry | 4 | 2018 | 1642 | 0.110 |
Why?
| | Antibodies | 2 | 2013 | 374 | 0.110 |
Why?
| | Cell Line | 6 | 2021 | 2651 | 0.100 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2005 | 169 | 0.100 |
Why?
| | Protein Disulfide-Isomerases | 1 | 2012 | 8 | 0.100 |
Why?
| | Contractile Proteins | 5 | 1996 | 16 | 0.100 |
Why?
| | Receptor, Adenosine A2B | 1 | 2012 | 30 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1180 | 0.100 |
Why?
| | Disease Progression | 3 | 2009 | 2418 | 0.100 |
Why?
| | Ventricular Function | 2 | 1991 | 57 | 0.100 |
Why?
| | Aorta | 2 | 2007 | 353 | 0.100 |
Why?
| | In Situ Nick-End Labeling | 2 | 2002 | 119 | 0.100 |
Why?
| | Enzyme Activation | 3 | 2002 | 793 | 0.100 |
Why?
| | Ventricular Pressure | 1 | 2011 | 37 | 0.100 |
Why?
| | Excitation Contraction Coupling | 1 | 2011 | 17 | 0.100 |
Why?
| | Natriuretic Peptides | 1 | 2011 | 8 | 0.100 |
Why?
| | Hyperbaric Oxygenation | 1 | 2011 | 37 | 0.100 |
Why?
| | Ventricular Fibrillation | 1 | 1991 | 51 | 0.090 |
Why?
| | Desmin | 1 | 2010 | 30 | 0.090 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 77 | 0.090 |
Why?
| | Peptide Fragments | 2 | 2007 | 675 | 0.090 |
Why?
| | Epoprostenol | 3 | 1986 | 133 | 0.090 |
Why?
| | Chest Pain | 1 | 1990 | 82 | 0.090 |
Why?
| | Promoter Regions, Genetic | 6 | 1994 | 1122 | 0.090 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 75 | 0.090 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2012 | 199 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 5 | 2012 | 2262 | 0.090 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 101 | 0.090 |
Why?
| | Cyclic AMP | 3 | 2008 | 227 | 0.090 |
Why?
| | Energy Metabolism | 3 | 2007 | 715 | 0.090 |
Why?
| | Extracellular Matrix Proteins | 1 | 2011 | 127 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2002 | 400 | 0.090 |
Why?
| | Cardiovascular Physiological Phenomena | 2 | 2006 | 40 | 0.090 |
Why?
| | Adult | 11 | 2020 | 30718 | 0.090 |
Why?
| | Sex Factors | 2 | 2013 | 1736 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2022 | 2604 | 0.080 |
Why?
| | Biopsy | 1 | 2013 | 1056 | 0.080 |
Why?
| | Prosthesis Design | 1 | 2011 | 287 | 0.080 |
Why?
| | Blotting, Northern | 2 | 2001 | 194 | 0.080 |
Why?
| | MicroRNAs | 2 | 2015 | 607 | 0.080 |
Why?
| | Mitochondria | 1 | 2014 | 750 | 0.080 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2012 | 420 | 0.080 |
Why?
| | Platelet Aggregation | 3 | 1986 | 94 | 0.080 |
Why?
| | Toxicogenetics | 1 | 2008 | 1 | 0.080 |
Why?
| | Mutation | 2 | 2018 | 3364 | 0.080 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 477 | 0.080 |
Why?
| | Digoxin | 1 | 2008 | 26 | 0.080 |
Why?
| | Cell Hypoxia | 2 | 2019 | 220 | 0.080 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2007 | 482 | 0.080 |
Why?
| | Arrhythmias, Cardiac | 2 | 2022 | 279 | 0.080 |
Why?
| | RNA | 2 | 2006 | 819 | 0.080 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 414 | 0.070 |
Why?
| | Embryo, Mammalian | 2 | 2020 | 214 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2002 | 274 | 0.070 |
Why?
| | Aged | 8 | 2020 | 19251 | 0.070 |
Why?
| | Consensus Sequence | 1 | 2007 | 70 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2001 | 1870 | 0.070 |
Why?
| | Protein Conformation | 1 | 2010 | 822 | 0.070 |
Why?
| | Ligation | 1 | 2007 | 77 | 0.070 |
Why?
| | Base Sequence | 5 | 1994 | 2114 | 0.070 |
Why?
| | Clinical Medicine | 1 | 2007 | 19 | 0.070 |
Why?
| | Biophysical Phenomena | 1 | 2007 | 63 | 0.070 |
Why?
| | Retrospective Studies | 3 | 2012 | 12608 | 0.070 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2007 | 43 | 0.070 |
Why?
| | Oxidation-Reduction | 2 | 2007 | 924 | 0.070 |
Why?
| | Heat Shock Transcription Factors | 1 | 2006 | 17 | 0.070 |
Why?
| | Pregnancy, Animal | 1 | 1987 | 52 | 0.070 |
Why?
| | Thyroid Hormones | 3 | 1993 | 53 | 0.070 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2007 | 107 | 0.070 |
Why?
| | DNA-Binding Proteins | 2 | 2006 | 1316 | 0.070 |
Why?
| | Chloramphenicol O-Acetyltransferase | 4 | 1994 | 38 | 0.070 |
Why?
| | Nitroimidazoles | 1 | 2006 | 6 | 0.070 |
Why?
| | Butyrates | 1 | 2007 | 53 | 0.070 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2006 | 33 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 390 | 0.070 |
Why?
| | Heat-Shock Proteins | 1 | 2006 | 113 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2013 | 3022 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2416 | 0.070 |
Why?
| | Heart Atria | 1 | 1986 | 110 | 0.070 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2006 | 78 | 0.070 |
Why?
| | Age Factors | 3 | 2008 | 2907 | 0.060 |
Why?
| | Transcription Factors | 2 | 2006 | 1528 | 0.060 |
Why?
| | Swimming | 5 | 1990 | 45 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2007 | 219 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1997 | 523 | 0.060 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 312 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2194 | 0.060 |
Why?
| | Phenylephrine | 2 | 2021 | 75 | 0.060 |
Why?
| | Animals, Genetically Modified | 1 | 2005 | 215 | 0.060 |
Why?
| | Enzyme Induction | 1 | 2004 | 85 | 0.060 |
Why?
| | Osteopontin | 1 | 2004 | 32 | 0.060 |
Why?
| | Ventricular Myosins | 1 | 2004 | 33 | 0.060 |
Why?
| | Kinetics | 3 | 2011 | 1569 | 0.060 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 158 | 0.060 |
Why?
| | Anticoagulants | 1 | 2008 | 549 | 0.060 |
Why?
| | Drug Resistance | 1 | 2004 | 162 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2578 | 0.060 |
Why?
| | Exercise Therapy | 1 | 1987 | 351 | 0.060 |
Why?
| | Mutagenesis | 1 | 2004 | 170 | 0.050 |
Why?
| | Cytokines | 1 | 2011 | 1853 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2004 | 616 | 0.050 |
Why?
| | Rats, Inbred F344 | 4 | 1997 | 245 | 0.050 |
Why?
| | Up-Regulation | 2 | 2007 | 820 | 0.050 |
Why?
| | Calcium-Transporting ATPases | 3 | 1993 | 35 | 0.050 |
Why?
| | United States | 3 | 2022 | 12295 | 0.050 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2002 | 28 | 0.050 |
Why?
| | Massachusetts | 1 | 2022 | 137 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 96 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 50 | 0.050 |
Why?
| | Chromones | 1 | 2002 | 35 | 0.050 |
Why?
| | Pulsatile Flow | 1 | 2002 | 54 | 0.050 |
Why?
| | GTP-Binding Proteins | 1 | 2002 | 142 | 0.050 |
Why?
| | Muscles | 3 | 1994 | 326 | 0.050 |
Why?
| | Androstadienes | 1 | 2002 | 97 | 0.050 |
Why?
| | Hypertrophy | 1 | 2001 | 110 | 0.050 |
Why?
| | Flavonoids | 1 | 2001 | 68 | 0.050 |
Why?
| | Lac Operon | 1 | 2001 | 46 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 310 | 0.050 |
Why?
| | beta-Galactosidase | 1 | 2001 | 63 | 0.050 |
Why?
| | Morpholines | 1 | 2002 | 103 | 0.050 |
Why?
| | Calcium Channels, L-Type | 1 | 2002 | 107 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2022 | 339 | 0.050 |
Why?
| | American Heart Association | 1 | 2022 | 266 | 0.050 |
Why?
| | Immunoblotting | 1 | 2001 | 281 | 0.050 |
Why?
| | Substrate Specificity | 1 | 2002 | 357 | 0.050 |
Why?
| | Culture Media | 1 | 2021 | 156 | 0.050 |
Why?
| | Sarcoplasmic Reticulum | 2 | 1993 | 43 | 0.050 |
Why?
| | Collagen | 2 | 2016 | 415 | 0.050 |
Why?
| | Cardiac Pacing, Artificial | 3 | 1998 | 79 | 0.040 |
Why?
| | Outpatients | 1 | 2023 | 330 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 36 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2018 | 1918 | 0.040 |
Why?
| | Protein Transport | 1 | 2001 | 400 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2002 | 549 | 0.040 |
Why?
| | Carotid Arteries | 1 | 2001 | 183 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 388 | 0.040 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 1999 | 14 | 0.040 |
Why?
| | Biomechanical Phenomena | 2 | 1996 | 677 | 0.040 |
Why?
| | Action Potentials | 2 | 2015 | 410 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 1999 | 53 | 0.040 |
Why?
| | Qa-SNARE Proteins | 1 | 2018 | 13 | 0.040 |
Why?
| | Organ Culture Techniques | 2 | 2007 | 143 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2018 | 18 | 0.040 |
Why?
| | Autophagy-Related Proteins | 1 | 2018 | 39 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 45 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 99 | 0.040 |
Why?
| | Blood Platelets | 3 | 1986 | 350 | 0.040 |
Why?
| | Tachycardia | 1 | 1998 | 49 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2002 | 396 | 0.040 |
Why?
| | Hypertension, Renal | 2 | 1989 | 12 | 0.040 |
Why?
| | Cell Survival | 1 | 2001 | 1024 | 0.040 |
Why?
| | Protein Biosynthesis | 2 | 1997 | 390 | 0.040 |
Why?
| | Research Design | 2 | 2022 | 946 | 0.040 |
Why?
| | Fatty Acids | 1 | 2021 | 386 | 0.040 |
Why?
| | Electrocardiography | 2 | 1991 | 560 | 0.040 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 1998 | 103 | 0.040 |
Why?
| | Streptozocin | 1 | 1997 | 16 | 0.040 |
Why?
| | Prazosin | 1 | 1997 | 26 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2018 | 119 | 0.040 |
Why?
| | Adrenergic alpha-Agonists | 1 | 1997 | 29 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2023 | 695 | 0.040 |
Why?
| | Death, Sudden | 1 | 1997 | 33 | 0.040 |
Why?
| | Biomarkers | 2 | 2013 | 3466 | 0.040 |
Why?
| | Pharmacogenomic Variants | 1 | 2017 | 34 | 0.040 |
Why?
| | Adenosine Triphosphate | 3 | 2011 | 431 | 0.040 |
Why?
| | Regional Blood Flow | 2 | 2012 | 414 | 0.040 |
Why?
| | Threonine | 1 | 1997 | 40 | 0.040 |
Why?
| | Epinephrine | 3 | 1988 | 167 | 0.040 |
Why?
| | Diastole | 2 | 1988 | 134 | 0.040 |
Why?
| | Integrases | 1 | 2018 | 117 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2011 | 9159 | 0.040 |
Why?
| | Europe | 1 | 2018 | 336 | 0.040 |
Why?
| | Proteomics | 1 | 2023 | 859 | 0.040 |
Why?
| | Alanine | 1 | 1997 | 103 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 372 | 0.030 |
Why?
| | DNA Methylation | 1 | 2020 | 498 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2018 | 433 | 0.030 |
Why?
| | Point Mutation | 1 | 1997 | 217 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1997 | 346 | 0.030 |
Why?
| | Peptides | 1 | 2001 | 864 | 0.030 |
Why?
| | Dogs | 1 | 1997 | 341 | 0.030 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 465 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 1993 | 78 | 0.030 |
Why?
| | Histones | 1 | 2020 | 540 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 544 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2016 | 74 | 0.030 |
Why?
| | MEF2 Transcription Factors | 1 | 2015 | 53 | 0.030 |
Why?
| | Creatine Kinase | 2 | 1997 | 72 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 129 | 0.030 |
Why?
| | Biological Transport | 1 | 1996 | 375 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1216 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 157 | 0.030 |
Why?
| | Phosphofructokinase-1 | 1 | 2014 | 6 | 0.030 |
Why?
| | T-Box Domain Proteins | 1 | 2015 | 93 | 0.030 |
Why?
| | Glucose Transporter Type 4 | 1 | 2014 | 36 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 1994 | 54 | 0.030 |
Why?
| | Luciferases | 2 | 1992 | 140 | 0.030 |
Why?
| | Oxygen Consumption | 3 | 1997 | 573 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2014 | 33 | 0.030 |
Why?
| | Antibody Specificity | 2 | 2013 | 176 | 0.030 |
Why?
| | Troponin | 1 | 1994 | 44 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 1994 | 41 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1087 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 317 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1536 | 0.030 |
Why?
| | Cytochalasin B | 1 | 1974 | 17 | 0.030 |
Why?
| | Binding Sites, Antibody | 1 | 1974 | 36 | 0.030 |
Why?
| | Connexin 43 | 1 | 1994 | 23 | 0.030 |
Why?
| | Adenoviridae | 1 | 1994 | 186 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 156 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 1997 | 1243 | 0.030 |
Why?
| | Thyroxine | 1 | 1994 | 59 | 0.030 |
Why?
| | Norepinephrine | 3 | 1992 | 207 | 0.030 |
Why?
| | Fibrosis | 1 | 2015 | 457 | 0.030 |
Why?
| | Erythrocytes | 2 | 1977 | 589 | 0.030 |
Why?
| | Quality Improvement | 1 | 2020 | 958 | 0.030 |
Why?
| | Cytomegalovirus | 1 | 1993 | 146 | 0.030 |
Why?
| | Immunodominant Epitopes | 1 | 2012 | 26 | 0.030 |
Why?
| | Avian Sarcoma Viruses | 1 | 1992 | 4 | 0.030 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 36 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 1994 | 340 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2005 | 2098 | 0.020 |
Why?
| | Protein Array Analysis | 1 | 2012 | 60 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 503 | 0.020 |
Why?
| | Genes, Viral | 1 | 1992 | 89 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2012 | 136 | 0.020 |
Why?
| | Rabbits | 3 | 1993 | 752 | 0.020 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1992 | 104 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2012 | 88 | 0.020 |
Why?
| | Perfusion | 2 | 1997 | 150 | 0.020 |
Why?
| | Cardioplegic Solutions | 1 | 2011 | 5 | 0.020 |
Why?
| | Phosphorus Radioisotopes | 1 | 2011 | 28 | 0.020 |
Why?
| | Buffers | 1 | 2011 | 54 | 0.020 |
Why?
| | Swine | 1 | 2013 | 704 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 168 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 1991 | 115 | 0.020 |
Why?
| | Muscle, Skeletal | 2 | 1997 | 1447 | 0.020 |
Why?
| | Antigen Presentation | 1 | 2012 | 189 | 0.020 |
Why?
| | New York City | 1 | 1990 | 74 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 174 | 0.020 |
Why?
| | Education, Medical, Continuing | 1 | 1991 | 119 | 0.020 |
Why?
| | Women's Health | 1 | 1992 | 271 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 235 | 0.020 |
Why?
| | Growth Hormone | 1 | 1990 | 99 | 0.020 |
Why?
| | T-Lymphocytes | 2 | 1994 | 1756 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2125 | 0.020 |
Why?
| | Gonadal Steroid Hormones | 1 | 1990 | 124 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 376 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1805 | 0.020 |
Why?
| | Genes | 1 | 1989 | 224 | 0.020 |
Why?
| | Phosphocreatine | 2 | 1999 | 36 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 425 | 0.020 |
Why?
| | Injections, Subcutaneous | 1 | 1988 | 137 | 0.020 |
Why?
| | Cell Size | 1 | 2008 | 81 | 0.020 |
Why?
| | Risk Factors | 2 | 1991 | 8697 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2007 | 42 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2007 | 37 | 0.020 |
Why?
| | DNA | 2 | 1991 | 1356 | 0.020 |
Why?
| | Heart Function Tests | 1 | 2007 | 59 | 0.020 |
Why?
| | Mitral Valve Stenosis | 1 | 1986 | 19 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 6264 | 0.020 |
Why?
| | Peptide Hormones | 1 | 2006 | 8 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 6417 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2800 | 0.020 |
Why?
| | Mitral Valve Insufficiency | 1 | 1986 | 63 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2007 | 440 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1265 | 0.020 |
Why?
| | Phentolamine | 1 | 1985 | 17 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 1985 | 81 | 0.020 |
Why?
| | Actins | 1 | 1987 | 383 | 0.020 |
Why?
| | Cardiovascular System | 1 | 2006 | 124 | 0.020 |
Why?
| | Vascular Resistance | 1 | 1986 | 338 | 0.010 |
Why?
| | Rats, Inbred BN | 1 | 2004 | 53 | 0.010 |
Why?
| | Homeostasis | 1 | 2008 | 577 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 2004 | 93 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1490 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1999 | 515 | 0.010 |
Why?
| | Prognosis | 1 | 1991 | 3339 | 0.010 |
Why?
| | Motor Activity | 1 | 1988 | 633 | 0.010 |
Why?
| | Phenanthridines | 1 | 2002 | 6 | 0.010 |
Why?
| | Benzophenanthridines | 1 | 2002 | 10 | 0.010 |
Why?
| | Aspirin | 1 | 1985 | 326 | 0.010 |
Why?
| | Alkaloids | 1 | 2002 | 22 | 0.010 |
Why?
| | Papillary Muscles | 1 | 2002 | 14 | 0.010 |
Why?
| | Mesylates | 1 | 2002 | 8 | 0.010 |
Why?
| | Detergents | 1 | 2002 | 41 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2002 | 153 | 0.010 |
Why?
| | Second Messenger Systems | 1 | 2002 | 32 | 0.010 |
Why?
| | Exercise | 1 | 1992 | 1609 | 0.010 |
Why?
| | Glucose | 1 | 2007 | 904 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2006 | 552 | 0.010 |
Why?
| | Membrane Potentials | 1 | 2002 | 251 | 0.010 |
Why?
| | Fetus | 2 | 1997 | 702 | 0.010 |
Why?
| | Pyrroles | 1 | 2002 | 185 | 0.010 |
Why?
| | Tamoxifen | 1 | 1981 | 192 | 0.010 |
Why?
| | Phosphates | 1 | 2001 | 160 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 2001 | 203 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1999 | 43 | 0.010 |
Why?
| | Early Growth Response Protein 1 | 1 | 1999 | 28 | 0.010 |
Why?
| | Binding Sites | 1 | 2002 | 1177 | 0.010 |
Why?
| | Deoxyuracil Nucleotides | 1 | 1998 | 2 | 0.010 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 1998 | 11 | 0.010 |
Why?
| | Constriction | 1 | 1998 | 45 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 171 | 0.010 |
Why?
| | DNA Ligases | 1 | 1998 | 15 | 0.010 |
Why?
| | Estrogens | 2 | 1992 | 315 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 2 | 1989 | 189 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 1998 | 38 | 0.010 |
Why?
| | Carbohydrates | 1 | 1977 | 57 | 0.010 |
Why?
| | Erythrocyte Membrane | 1 | 1977 | 50 | 0.010 |
Why?
| | Protein Kinase C-alpha | 1 | 1997 | 41 | 0.010 |
Why?
| | Protein Kinase C-delta | 1 | 1997 | 70 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3069 | 0.010 |
Why?
| | beta-Thromboglobulin | 2 | 1986 | 3 | 0.010 |
Why?
| | Thromboxane B2 | 2 | 1986 | 27 | 0.010 |
Why?
| | Young Adult | 1 | 2011 | 10470 | 0.010 |
Why?
| | Running | 2 | 1988 | 209 | 0.010 |
Why?
| | Pregnancy | 1 | 1987 | 5548 | 0.010 |
Why?
| | RNA, Transfer, Leu | 1 | 1994 | 7 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1999 | 594 | 0.010 |
Why?
| | Melanoma | 1 | 1981 | 651 | 0.010 |
Why?
| | Atrophy | 1 | 1994 | 152 | 0.010 |
Why?
| | Immune Adherence Reaction | 1 | 1974 | 2 | 0.010 |
Why?
| | Leucine | 1 | 1994 | 108 | 0.010 |
Why?
| | Intercellular Junctions | 1 | 1994 | 34 | 0.010 |
Why?
| | Neuraminidase | 1 | 1974 | 22 | 0.010 |
Why?
| | Vibrio cholerae | 1 | 1974 | 9 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1997 | 1000 | 0.010 |
Why?
| | Genes, Reporter | 1 | 1994 | 257 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1994 | 324 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 1981 | 761 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 1994 | 177 | 0.010 |
Why?
| | Chick Embryo | 1 | 1993 | 122 | 0.010 |
Why?
| | Immune System | 1 | 1994 | 173 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 17889 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1993 | 290 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1993 | 309 | 0.010 |
Why?
| | Oxygen | 1 | 1997 | 837 | 0.010 |
Why?
| | Denervation | 1 | 1992 | 19 | 0.010 |
Why?
| | Sheep | 1 | 1974 | 764 | 0.010 |
Why?
| | Triiodothyronine | 1 | 1991 | 43 | 0.010 |
Why?
| | Temperature | 1 | 1974 | 587 | 0.010 |
Why?
| | Hypothyroidism | 1 | 1991 | 65 | 0.010 |
Why?
| | Heart Valve Diseases | 1 | 1992 | 116 | 0.010 |
Why?
| | Models, Cardiovascular | 1 | 1992 | 172 | 0.010 |
Why?
| | Injections | 1 | 1991 | 161 | 0.010 |
Why?
| | Orchiectomy | 1 | 1990 | 57 | 0.010 |
Why?
| | Plasmids | 1 | 1991 | 345 | 0.010 |
Why?
| | Ovariectomy | 1 | 1990 | 117 | 0.010 |
Why?
| | Hematocrit | 1 | 1990 | 86 | 0.010 |
Why?
| | DNA Probes | 1 | 1989 | 59 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1989 | 78 | 0.010 |
Why?
| | Chickens | 1 | 1989 | 183 | 0.000 |
Why?
| | Lactates | 1 | 1988 | 83 | 0.000 |
Why?
| | Child | 1 | 1986 | 18488 | 0.000 |
Why?
| | Testosterone | 1 | 1990 | 337 | 0.000 |
Why?
| | Kidney | 1 | 1993 | 1207 | 0.000 |
Why?
| | Lactic Acid | 1 | 1988 | 275 | 0.000 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 1986 | 21 | 0.000 |
Why?
| | Lymphatic Metastasis | 1 | 1981 | 276 | 0.000 |
Why?
| | Hemagglutination | 1 | 1977 | 7 | 0.000 |
Why?
| | Mitogens | 1 | 1977 | 58 | 0.000 |
Why?
| | Antibody Formation | 1 | 1977 | 273 | 0.000 |
Why?
| | Lymphocytes | 1 | 1977 | 344 | 0.000 |
Why?
|
|
Buttrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|